Cliff Asness's DXCM Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 3.1 M shares of DexCom, Inc. (DXCM) worth $205.93 M, representing 0.11% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 53 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in DXCM, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2025, adding 2.66 M shares. Largest reduction occurred in Q2 2019, reducing 1.59 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's DexCom (DXCM) Holding Value Over Time
Track share changes against reported price movement
Quarterly DexCom (DXCM) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2.66 M | Add 597.83% | 3.1 M | $66.37 |
| Q3 2025 | -179,750 | Reduce 28.79% | 444,631 | $66.96 |
| Q2 2025 | -84,652 | Reduce 11.94% | 624,381 | $86.95 |
| Q1 2025 | +100,824 | Add 16.58% | 709,033 | $66.80 |
| Q4 2024 | +410,914 | Add 208.27% | 608,209 | $77.77 |
| Q3 2024 | +112,278 | Add 132.07% | 197,295 | $67.04 |
| Q2 2024 | -118,657 | Reduce 58.26% | 85,017 | $113.37 |
| Q1 2024 | +70,964 | Add 53.47% | 203,674 | $138.70 |
| Q4 2023 | +86,717 | Add 188.54% | 132,710 | $124.03 |
| Q3 2023 | -53,099 | Reduce 53.59% | 45,993 | $93.30 |
| Q2 2023 | +38,973 | Add 64.83% | 99,092 | $128.51 |
| Q1 2023 | +8,218 | Add 15.83% | 60,119 | $116.18 |
| Q4 2022 | -24,136 | Reduce 31.74% | 51,901 | $111.32 |
| Q3 2022 | +27,066 | Add 55.27% | 76,037 | $80.54 |
| Q2 2022 | +8,631 | Add 21.40% | 48,971 | $74.23 |
| Q1 2022 | +10,756 | Add 36.36% | 40,340 | $127.89 |
| Q4 2021 | +4 | Add 0.01% | 29,584 | $134.23 |
| Q3 2021 | -8 | Reduce 0.03% | 29,580 | $136.71 |
| Q2 2021 | -5,252 | Reduce 15.07% | 29,588 | $106.33 |
| Q1 2021 | -26,136 | Reduce 42.86% | 34,840 | $88.69 |
| Q4 2020 | -4,488 | Reduce 6.86% | 60,976 | $91.00 |
| Q3 2020 | +12,292 | Add 23.12% | 65,464 | $100.71 |
| Q2 2020 | +1,036 | Add 1.99% | 53,172 | $99.15 |
| Q1 2020 | +15,476 | Add 42.21% | 52,136 | $67.32 |
| Q4 2019 | -18,572 | Reduce 33.63% | 36,660 | $54.69 |
| Q3 2019 | -351,636 | Reduce 86.43% | 55,232 | $37.19 |
| Q2 2019 | -1.59 M | Reduce 79.66% | 406,868 | $37.46 |
| Q1 2019 | +502,816 | Add 33.58% | 2 M | $29.61 |
| Q4 2018 | +928,220 | Add 163.06% | 1.5 M | $29.95 |
| Q3 2018 | +472,132 | Add 486.17% | 569,244 | $35.76 |
| Q2 2018 | -11,224 | Reduce 10.36% | 97,112 | $23.75 |
| Q1 2018 | -139,684 | Reduce 56.32% | 108,336 | $18.54 |
| Q4 2017 | -146,468 | Reduce 37.13% | 248,020 | $14.35 |
| Q3 2017 | +6,800 | Add 1.75% | 394,488 | $12.23 |
| Q2 2017 | +90,844 | Add 30.60% | 387,688 | $18.29 |
| Q1 2017 | +32,548 | Add 12.31% | 296,844 | $21.18 |
| Q4 2016 | +110,208 | Add 71.52% | 264,296 | $14.93 |
| Q3 2016 | +6,456 | Add 4.37% | 154,088 | $21.92 |
| Q2 2016 | -61,880 | Reduce 29.54% | 147,632 | $19.83 |
| Q1 2016 | -864,368 | Reduce 80.49% | 209,512 | $16.98 |
| Q4 2015 | +715,432 | Add 199.59% | 1.07 M | $20.48 |
| Q3 2015 | +84,384 | Add 30.79% | 358,448 | $21.46 |
| Q2 2015 | -43,832 | Reduce 13.79% | 274,064 | $20.00 |
| Q1 2015 | -37,600 | Reduce 10.58% | 317,896 | $15.59 |
| Q4 2014 | -238,632 | Reduce 40.17% | 355,496 | $13.76 |
| Q3 2014 | -340,400 | Reduce 36.42% | 594,128 | $10.00 |
| Q2 2014 | +685,600 | Add 275.42% | 934,528 | $9.92 |
| Q1 2014 | +22,000 | Add 9.69% | 248,928 | $10.34 |
| Q4 2013 | +8,484 | Add 3.88% | 226,928 | $8.85 |
| Q3 2013 | -18,800 | Reduce 7.92% | 218,444 | $7.06 |
| Q2 2013 | +237,244 | Add 0.00% | 237,244 | $5.61 |
| Q4 2012 | +217,180 | Add 0.00% | 217,180 | $3.40 |
Cliff Asness's DexCom Investment FAQs
Cliff Asness first purchased DexCom, Inc. (DXCM) in Q4 2012, acquiring 217,180 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held DexCom, Inc. (DXCM) for 53 quarters since Q4 2012.
Cliff Asness's largest addition to DexCom, Inc. (DXCM) was in Q4 2025, adding 3,102,789 shares worth $205.93 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 3,102,789 shares of DexCom, Inc. (DXCM), valued at approximately $205.93 M.
As of the Q4 2025 filing, DexCom, Inc. (DXCM) represents approximately 0.11% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in DexCom, Inc. (DXCM) was 3,102,789 shares, as reported at the end of Q4 2025.